Questcor (QCOR +2.3%) rallies after SunTrust and Lazard respond positively to a...
Questcor (QCOR +2.3%) rallies after SunTrust and Lazard respond positively to a UnitedHealth/Oxford policy update letter (.pdf) regarding Acthar gel coverage, which produced a selloff on Friday. SunTrust argues the update should reassure investors Acthar has value in treating nephrology and MS, while Lazard claims it's a positive given investor fears following Aetna's move to limit coverage. 40.3% of Questcor's float was shorted as of Sep. 14.
From other sites
at Nasdaq.com (Apr 9, 2015)
at Zacks.com (Mar 24, 2015)
at Zacks.com (Mar 6, 2015)
at Nasdaq.com (Mar 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs